Geneos Therapeutics Company
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Total Funding:
39500000
Headquarters:
Plymouth Meeting, Pennsylvania, United States
Funding Status:
Early Stage Venture
Employee Number:
1-10
Estimated Revenue:
$1M to $10M
Last Funding Type:
Series A
Last Funding Date:
2022-03-24
Investors Number:
5
Founded Date:
2016-08-01
Industry:
DNA